Expression of concern
Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis to Inform Clinical Guidelines
Paper Information
Record ID:
35387
Author(s):
Publication Date:
June 21, 2021
Retraction Date:
February 07, 2022
(3.8 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Population Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom
- Evidence-based Medicine Consultancy, Bath, United Kingdom
- Emergency Department, Princess Elizabeth Hospital, Guernsey, United Kingdom
- Division of Gastroenterology, Ulster Hospital, Dundonald, Belfast, Northern Ireland, United Kingdom
Country:
🇬🇧 United KingdomArticle Type:
Publisher:
Wolters Kluwer - Lippincott Williams & Wilkins
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1097/CND.0000000000000400Citations (236)
236
Total Citations160
Post-Retraction(67.8%)
76
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
11
Within 30 days
104
Within 1 year
28
After 2+ years
1234
Days since retraction (latest)
Ivermectin and the Integrity of Healthcare Evidence During COVID-19
Dónal P O’Mathúna
Frontiers in Public Health
Open Access
Published: Mar 2022
10 citations
10 citations
22 days after retraction
Systematic Review and Meta-analysis of Ivermectin for Treatment of COVID-19: Evidence Beyond the Hype
Milena Soriano Marcolino, Karina Cardoso Meira, Nathália Sernizon Guimarães et al. (9 authors)
Research Square (Research Square)
Open Access
Published: Feb 2022
18 days after retraction
Safety and Efficacy of a MEURI Program for the Use of High Dose Ivermectin in COVID-19 Patients
Marcos Mayer, Alejandro Krolewiecki, Alejandro Ferrero et al. (14 authors)
Frontiers in Public Health
Open Access
Published: Feb 2022
3 citations
3 citations
15 days after retraction
Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities
Steven Lim, Chee Peng Hor, Kim Heng Tay et al. (100 authors)
JAMA Internal Medicine
Open Access
Published: Feb 2022
91 citations
91 citations
11 days after retraction
Ofeleein i mi Vlaptin—Volume II: Immunity Following Infection or mRNA Vaccination, Drug Therapies and Non-Pharmacological Management at Post-Two Years SARS-CoV-2 Pandemic
Jannis Kountouras, Dimitra Gialamprinou, Georgios Kotronis et al. (11 authors)
Medicina
Open Access
Published: Feb 2022
6 citations
6 citations
10 days after retraction
Zinc augments the antiviral potential of HCQ/CQ and ivermectin to reduce the risks of more serious outcomes from COVID-19 infection
Alberto Boretti
Journal of Trace Elements in Medicine and Biology
Open Access
Published: Feb 2022
10 citations
10 citations
10 days after retraction
Using a Systems Approach to Explore the Mechanisms of Interaction Between Severe Covid-19 and Its Coronary Heart Disease Complications
Albertus A. Meyer, E.H. Mathews, Andries Gous et al. (4 authors)
Frontiers in Cardiovascular Medicine
Open Access
Published: Feb 2022
1 citation
1 citation
9 days after retraction
Unresolved COVID Controversies: ‘Normal science’ and potential non-scientific influences
Carlos F. Cáceres
Global Public Health
Published: Feb 2022
11 citations
11 citations
8 days after retraction
Meta-Analyses Do Not Establish Improved Mortality With Ivermectin Use in COVID-19
Steven G. Rothrock, Kurt Weber, Philip Giordano et al. (4 authors)
American Journal of Therapeutics
Open Access
Published: Feb 2022
7 citations
7 citations
3 days after retraction
Effectiveness of Ivermectin-Based Multidrug Therapy in Severely Hypoxic, Ambulatory COVID-19 Patients
Sabine Hazan, Sonya Davé, Anoja W. Gunaratne et al. (7 authors)
Future Microbiology
Open Access
Published: Feb 2022
27 citations
27 citations
2 days after retraction
Analytical Method Development And Validation Parameters Of Drug Ivermectin
Sonia Goswami, K. Nagarajan, Richa Goel et al. (7 authors)
International Journal of Life Science and Pharma Research
Open Access
Published: Jan 2022
7 days before retraction
Approaches to the Potential Therapy of COVID-19: A General Overview from the Medicinal Chemistry Perspective
J. Carlos Menéndez
Molecules
Open Access
Published: Jan 2022
32 citations
32 citations
18 days before retraction
Ivermectin for COVID-19: Addressing Potential Bias and Medical Fraud
Andrew Hill, Manya Mirchandani, Victoria Pilkington
Open Forum Infectious Diseases
Open Access
Published: Jan 2022
52 citations
52 citations
21 days before retraction
Monoclonal Antibodies and their Target Specificity Against SARS-CoV-2 Infections: Perspectives and Challenges
Mohammed Ali Bakkari, Sivakumar S. Moni, Muhammad H. Sultan et al. (4 authors)
Recent Patents on Biotechnology
Open Access
Published: Jan 2022
5 citations
5 citations
31 days before retraction
Quantitative in silico analysis of SARS-CoV-2 S-RBD omicron mutant transmissibility
Toshihiko Hanai
Talanta
Open Access
Published: Jan 2022
24 citations
24 citations
31 days before retraction
High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial
Dora Buonfrate, Fabio Chesini, Davide Martini et al. (18 authors)
International Journal of Antimicrobial Agents
Open Access
Published: Jan 2022
51 citations
51 citations
32 days before retraction
The role of massive demographic databases in intractable illnesses: Denomics for dementia
Mark M. Stecker, Morgan R. Peltier, Allison B. Reiss
AIMS Public Health
Open Access
Published: Jan 2022
3 citations
3 citations
37 days before retraction
SARS-CoV-2 and the Nucleus
Mengqi Chen, Yue Ma, Wakam Chang
International Journal of Biological Sciences
Open Access
Published: Jan 2022
20 citations
20 citations
37 days before retraction
Drug safety of frequently used drugs and substances for self-medication in COVID-19
Daniela Baracaldo-Santamaría, Santiago Pabón-Londoño, Luis Carlos Rojas-Rodríguez
Therapeutic Advances in Drug Safety
Open Access
Published: Jan 2022
24 citations
24 citations
37 days before retraction
Systematic Review and Meta-Analysis of Ivermectin for Treatment of COVID-19: Evidence Beyond the Hype
Milena Soriano Marcolino, Karina Cardoso Meira, Victor Schulthais Chagas et al. (9 authors)
SSRN Electronic Journal
Open Access
Published: Jan 2022
2 citations
2 citations
37 days before retraction
Re: “Commentary” by Rothrock et al. “Meta-Analyses Did Not Establish Improved Mortality With Ivermectin Use in COVID-19”
Andrew Bryant, Theresa A Lawrie, Edmund J. Fordham et al. (4 authors)
American Journal of Therapeutics
Open Access
Published: Dec 2021
3 citations
3 citations
40 days before retraction
Channels and Transporters of the Pulmonary Lamellar Body in Health and Disease
Paul Dietl, Manfred Frick
Cells
Open Access
Published: Dec 2021
12 citations
12 citations
45 days before retraction
Bias as a source of inconsistency in ivermectin trials for COVID-19: A systematic review. Ivermectin's suggested benefits are mainly based on potentially biased results
Ariel Izcovich, Sasha Peiris, Martín Ragusa et al. (7 authors)
Journal of Clinical Epidemiology
Open Access
Published: Dec 2021
26 citations
26 citations
51 days before retraction
Determinants of Outcome Among Critically Ill Police Personnel With COVID-19: A Retrospective Observational Study From Andhra Pradesh, India
Limalemla Jamir, Mukesh Tripathi, Sumita Shankar et al. (6 authors)
Cureus
Open Access
Published: Dec 2021
3 citations
3 citations
56 days before retraction
Antiviral Activity of the Rhamnolipids Mixture from the Antarctic Bacterium Pseudomonas gessardii M15 against Herpes Simplex Viruses and Coronaviruses
Rosa Giugliano, Carmine Buonocore, Carla Zannella et al. (10 authors)
Pharmaceutics
Open Access
Published: Dec 2021
29 citations
29 citations
61 days before retraction
Covid-19 pandemic: What is the truth?
Russell L. Blaylock
Surgical Neurology International
Open Access
Published: Dec 2021
6 citations
6 citations
61 days before retraction
Meta-Analyses Do Not Establish Improved Mortality With Ivermectin Use in COVID-19
Steven G. Rothrock, Kurt Weber, Philip Giordano et al. (4 authors)
American Journal of Therapeutics
Open Access
Published: Dec 2021
11 citations
11 citations
62 days before retraction
The military as a neglected pathogen transmitter, from the nineteenth century to COVID-19: a systematic review
Claudia Chaufan, Ilinca A. Dutescu, Hanah Fekre et al. (5 authors)
Global Health Research and Policy
Open Access
Published: Dec 2021
6 citations
6 citations
68 days before retraction
Is there any prophylactic role for ivermectin in COVID‐19—A literature summary
Kabir Sardana, Sinu Rose Mathachan
Journal of Cosmetic Dermatology
Published: Nov 2021
1 citation
1 citation
73 days before retraction
Licorice (Glycyrrhiza glabra) Extracts-Suitable Pharmacological Interventions for COVID-19? A Review
Joji Abraham, Singarayer Florentine
Plants
Open Access
Published: Nov 2021
25 citations
25 citations
73 days before retraction
Ivermectin
Patricia Anne O’Malley
Clinical Nurse Specialist
Open Access
Published: Nov 2021
1 citation
1 citation
75 days before retraction
Another Cautionary Lesson from COVID Research
Christine Grady
The American Journal of Bioethics
Open Access
Published: Nov 2021
2 citations
2 citations
77 days before retraction
Steroids Induced Black Fungus Infection in India During the May 2021 COVID-19 Outbreak
Alberto Boretti
Indian Journal of Otolaryngology and Head & Neck Surgery
Open Access
Published: Nov 2021
4 citations
4 citations
84 days before retraction
Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview
Ahmed A. Al‐Karmalawy, Raya Soltane, Ayman Abo Elmaaty et al. (11 authors)
Vaccines
Open Access
Published: Nov 2021
39 citations
39 citations
87 days before retraction
Rapid increase of SpO2 on room air for 34 severe COVID-19 patients after ivermectin-based combination treatment: 55-62% normalization within 12-24 hours
Jacqueline C Stone, Pisirai Ndarukwa, David Scheim et al. (7 authors)
Research Square (Research Square)
Published: Nov 2021
6 citations
6 citations
90 days before retraction
COVID-19-Associated acute respiratory distress syndrome (CARDS): Mechanistic insights on therapeutic intervention and emerging trends
Komal Thapa, Nitin Verma, Thakur Gurjeet Singh et al. (6 authors)
International Immunopharmacology
Open Access
Published: Nov 2021
11 citations
11 citations
96 days before retraction
Identification and Development of Therapeutics for COVID-19
Halie M. Rando, Nils Wellhausen, Soumita Ghosh et al. (23 authors)
mSystems
Open Access
Published: Nov 2021
19 citations
19 citations
97 days before retraction
Drug Repurposing Against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
Sarah Aherfi, Bruno Pradines, Christian Devaux et al. (7 authors)
Future Microbiology
Open Access
Published: Nov 2021
35 citations
35 citations
98 days before retraction
Reposicionamiento de ivermectina frente a COVID-19: evidencias científicas que avalan su potencial preventivo y terapéutico
A. Lifschitz, Luis E. Álvarez, Laura Ceballos et al. (4 authors)
FAVE Sección Ciencias Veterinarias
Open Access
Published: Oct 2021
101 days before retraction
Indicaciones de la ivermectina oral en dermatología
D. Morgado‐Carrasco, Jaime Piquero‐Casals, Sebastián Podlipnik
Piel
Published: Oct 2021
103 days before retraction
Long-term consequences of the misuse of ivermectin data
Carlos Álvarez, Jackie Cassell, Claudia M. Y. A. Donkor et al. (8 authors)
The Lancet Infectious Diseases
Open Access
Published: Oct 2021
8 citations
8 citations
111 days before retraction
Favipiravir and Ivermectin Showed in Vitro Synergistic Antiviral Activity against SARS-CoV-2
Kunlakanya Jitobaom, Chompunuch Boonarkart, Suwimon Manopwisedjaroen et al. (8 authors)
Research Square (Research Square)
Published: Oct 2021
3 citations
3 citations
116 days before retraction
Venovenous extracorporeal membrane oxygenation in patients with COVID-19 respiratory failure
J.W. Awori Hayanga, Subhasis Chatterjee, Bo Soo Kim et al. (7 authors)
Journal of Thoracic and Cardiovascular Surgery
Open Access
Published: Oct 2021
12 citations
12 citations
117 days before retraction
Rapid Response: Ivermectin in Covid-19
Andrew Bryant, Theresa A Lawrie, Edmund J. Fordham et al. (4 authors)
Unknown Journal
Open Access
Published: Oct 2021
117 days before retraction
The military as a neglected pathogen transmitter, from the 19th century to COVID-19: A systematic review
Claudia Chaufan, Ilinca A. Dutescu, Hanah Fekre et al. (5 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Oct 2021
118 days before retraction
The uses and abuses of systematic reviews
Edmund J. Fordham, Theresa A Lawrie, Katherine S. MacGilchrist et al. (4 authors)
Unknown Journal
Published: Oct 2021
2 citations
2 citations
123 days before retraction
Efficacy and safety of ivermectin for COVID-19
Alok Singh, Pranav G. Sheth, Suryaprakash Dhaneria et al. (4 authors)
Asian Pacific Journal of Tropical Medicine
Open Access
Published: Oct 2021
3 citations
3 citations
129 days before retraction
Ivermectin Research Should Not Be Used to Promote Vaccine Opposition
Peter Manu
American Journal of Therapeutics
Open Access
Published: Sep 2021
1 citation
1 citation
133 days before retraction
A hitchhiker's guide through the COVID-19 galaxy
Susanna Felsenstein, Andreas Reiff
Clinical Immunology
Open Access
Published: Sep 2021
4 citations
4 citations
136 days before retraction
The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable
Jack M. Lawrence, Gideon Meyerowitz‐Katz, James Heathers et al. (5 authors)
Nature Medicine
Open Access
Published: Sep 2021
72 citations
72 citations
138 days before retraction
Quick Stats
Total Citations:
236
Years Since Retraction:
3.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025